UNICA IRIS Institutional Research Information System

DE LOGU, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 163.487
NA - Nord America 7.400
AS - Asia 1.151
SA - Sud America 50
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 172.105
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 160.831
US - Stati Uniti d'America 7.288
UA - Ucraina 1.044
CN - Cina 844
SE - Svezia 573
DE - Germania 303
GB - Regno Unito 258
FI - Finlandia 255
SG - Singapore 224
FR - Francia 100
CA - Canada 63
MX - Messico 44
IN - India 36
RU - Federazione Russa 33
BE - Belgio 21
NL - Olanda 15
PE - Perù 11
CO - Colombia 9
EC - Ecuador 9
KR - Corea 9
TR - Turchia 8
CH - Svizzera 7
MD - Moldavia 7
CL - Cile 6
EG - Egitto 6
ES - Italia 6
EU - Europa 6
IE - Irlanda 6
PK - Pakistan 6
BR - Brasile 5
IQ - Iraq 5
PL - Polonia 5
RO - Romania 5
HK - Hong Kong 4
IR - Iran 4
PY - Paraguay 4
SM - San Marino 4
VN - Vietnam 4
AL - Albania 3
IL - Israele 3
UY - Uruguay 3
AR - Argentina 2
CR - Costa Rica 2
CU - Cuba 2
DK - Danimarca 2
MA - Marocco 2
MU - Mauritius 2
AZ - Azerbaigian 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
HU - Ungheria 1
JP - Giappone 1
LU - Lussemburgo 1
LV - Lettonia 1
MT - Malta 1
MY - Malesia 1
PR - Porto Rico 1
PT - Portogallo 1
SA - Arabia Saudita 1
VE - Venezuela 1
Totale 172.105
Salva come PNG Salva come JPEG
Città #
Cagliari 156.499
Uta 2.992
Chandler 764
Woodbridge 634
Fairfield 625
Jacksonville 594
Boardman 566
Ann Arbor 491
Ashburn 456
Nyköping 406
Houston 403
Wilmington 323
Seattle 253
Cambridge 214
New York 201
Boston 171
Nanjing 161
Helsinki 133
Beijing 128
Dearborn 125
Santa Clara 109
Singapore 104
Milan 103
Shanghai 76
Redwood City 68
Rome 66
Shenyang 61
Nanchang 59
Toronto 54
Hebei 49
Verona 46
Tianjin 43
Changsha 37
San Diego 35
Jiaxing 33
Los Angeles 32
Orange 30
Zhengzhou 26
Washington 25
Jinan 24
Norwalk 23
Guangzhou 21
Ningbo 21
Brussels 17
London 16
Atlanta 15
Sassari 15
Auburn Hills 14
Bologna 13
Hefei 13
Mountain View 13
Genoa 12
Saint Petersburg 12
Hangzhou 11
Caserta 10
Catania 10
Cedar Knolls 10
Palermo 10
Pune 10
Sìnnai 10
Trezzano sul Naviglio 10
Turin 9
Berlin 8
Florence 8
Napoli 8
Seoul 8
Taizhou 8
Trento 8
Walnut 8
Borås 7
Padova 7
Pisa 7
Redmond 7
Bari 6
Dallas 6
Naples 6
Parma 6
Pescara 6
Serra 6
Siena 6
Taranto 6
Wuhan 6
Chicago 5
Chisinau 5
Falls Church 5
Girasole 5
Pandino 5
Pavia 5
Bergamo 4
Cassano Magnago 4
Castelluccio dei Sauri 4
Chiswick 4
Colli Del Tronto 4
Dong Ket 4
Dublin 4
Filottrano 4
Fuzhou 4
Itauguá 4
Lima 4
Modena 4
Totale 167.730
Salva come PNG Salva come JPEG
Nome #
Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida 4.909
Attività antimicobatterica di nuovi S-alchilisotiosemicarbazoni e potenziamento dell'attività di rifabutina, rifampicina e amikacina nei confronti di Mycobacterium avium 4.518
Limonoids from Melia azedarach fruits as inhibitors of flaviviruses and mycobacterium tubercolosis 4.356
2-(2-cycloalkylidene hydrazin-1-yl)-4-aryl-1,3-thiazoles: a promising class of antifungal agents 4.260
Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases 3.400
Antiherpevirus activity of Artemisia arborescens essential oil and inhibition of lateral diffusion in Vero cells 2.949
MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212 2.634
Discovery of in vitro antitubercular agents through in silico ligand-based approaches 2.242
Design, synthesis, SAR and biological investigation of 3-(carboxymethyl)rhodanine and aminothiazole inhibitors of Mycobacterium tuberculosis Zmp1 2.205
New pyrrole derivatives of BM 212: a new class of antimycobacterial agents. Design, synthesis, biological evaluation and study of their mode of action. 2.161
Naturally occurring Diels-Alder-type adducts from Morus nigra as potent inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase B 2.133
Improved BM212 MmpL3 inhibitor analogue shows efficacy in acute murine model of tuberculosis infection 2.106
Developing pyrrole-derived antimycobacterial agents: a rational lead optimization approach 2.101
Terapia delle infezioni sostenute da Candida spp.: nuovi approcci mediante derivati isotiosemicarbazonici. 2.077
HPLC-DAD-MS analysis and antiviral activity of different extracts and isolated costituents from Bituminaria bituminosa 2.061
Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis 2.002
In vitro activity of 2-cyclohexylidenhydrazo-4-phenil-thiazole compared with those of amphotericin b and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans 1.964
Imidazole and 1,2,4-triazole-based derivatives gifted with antitubercular activity: Cytotoxicity and computational assessment 1.955
null 1.953
null 1.949
Improving the physical chemical properties of a very promising class of pyrrole antimycobacterial agents 1.939
2-Acylhydrazino-5-arylpyrrole derivatives: Synthesis and antifungal activity evaluation 1.912
Antimycobacterial activity of new N1-[1-[1-aryl-3-[4-(1H-imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone derivatives 1.879
1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis and microbiological evaluation 1.862
Synthesis and anti-microbial activity evaluation of some new 1-benzoyl-isothiosemicarbazides. 1.838
Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation 1.835
null 1.829
Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones 1.828
The MmpL3 protein is responsible for resistance to BM212, a lead antitubercular drug 1.821
In vivo potent BM635 analogue with improved drug-like properties 1.759
null 1.749
1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings 1.748
Nuove strategie per lo sviluppo di farmaci antitubercolari: caratterizzazione di target alternativi e di fattori di virulenza in Mycobacterium tuberculosis 1.694
Design, synthesis and antimycobacterial activity of benzoxazinone derivatives and open-ring analogues: Preliminary data and computational analysis 1.657
Sherris. Microbiologia medica 1.620
Individuazione di nuovi target in MDR e XDR Mycobacterium tuberculosis mediante 1,5-difenil- e 1,5-diaril-2-etil-pirroli per lo sviluppo di nuovi agenti antitubercolari 1.605
Synthesis and anti-microbial activity of isothiosemicarbazones and cyclic analogues 1.595
Synthesis and antimicrobial activity of novel arylidenisothiosemicarbazones 1.560
Attività fungicida di analoghi ciclici isotiosemicarbazonici nei confronti di isolati clinici di Candida spp. 1.535
Synthesis and biological evaluation of new enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis 1.515
Effetti sulla attività di AmB nei confronti di biofilm di C. albicans in seguito ad esposizione a EM01D2 e fluconazolo. 1.485
Novel N-aryl- and N-heteryl-phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and MDR Mycobacterium tuberculosis 1.480
Phenazine-1-carboxilyc acid derivatives suppressing the RNA polymerase as potential agents for the treatment of infections sustained by drug-resistant and MDR Mycobacterium tuberculosis 1.443
Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis 1.415
Identification of a novel pyrrole derivative endowed with antimycobacterial activity and protection index comparable to that of the current antitubercular drugs streptomycin and rifampin 1.394
Effetto di Inibitori delle COX-1 e COX-2 sullo sviluppo del biofilm di Candida albicans: studio della associazione di FANS e derivati azolici per la profilassi delle infezioni fungine contratte in ambiente ospedaliero 1.386
dentification of a new Chemical Class of Potent Antimycobacterial Compounds 1.362
Derivati ciclici isotiosemicarbazonici come approccio alternativo nella terapia delle infezioni sostenute da Candida spp. 1.359
BM 579: a novel pyrrole derivative with improved antimycobacterial activity 1.342
Synergistic interaction in vitro between rifabutin and newly synthesized S-alkylisothiosemicarbazones derivatives against mycobacterium avium 1.340
Novel Pyrazole-Containing Compounds Active against Mycobacterium tuberculosis 1.277
Nuovo sistema di fermentazione in semi-solido per la produzione di enzimi cellulosolitici 1.260
Design, synthesis and microbiological characterization of 1,5-diphenyl and 1,5-diaryl-2-ethylpyrrole derivatives as new potential agents of infections sustained by MDR and XDR Mycobacterium tuberculosis. 1.253
Sul trattamento microbiologico delle acque di vegetazione 1.186
Infezioni nosocomiali da Pseudomonas maltophilia in un reparto di terapia intensiva per neonat 1.176
Synergistic interactions in vitro between Rifabutin and newly synthesized s-alkylthiosemicarbazone derivatives against M. avium 1.172
null 1.144
Saggi e dosaggi microbiologici della Farmacopea 1.143
Effetto di FANS sulla formazione di biofilm di Candida albicans e potenziamento della attività di farmaci antifungini 1.118
Studio di un metodo rapido mediante riduzione di XTT per la determinazione della resistenza in Mycobacterium tuberculosis 1.117
BM212 and its derivatives: lead optimization of a new class of antimycobacterial agents. 1.113
Pyrrole derivatives of BM212 as novel antimycobacterial agents Design, synthesis, biological evaluation and study of their mode of action 1.085
null 1.070
An investigation of the biological effect of structural modifications of isothiosemicarbazones and their cyclic analogues 1.029
New pyrrole derivatives of BM 212: a new class of antimycobacterial agents.Design, synthesis, biological evaluation and study of their mode of action. 1.008
Design and synthesis of 1,5-diaryl-2-ethyl pyrrole derivatives and their evaluation as antimycobacterial agents 1.002
Antimycobacterial Activiy of New 1,4-Benzoxazine-2-one derivatives and its 2-(arylamino)-4-oxobut-2-enoate, ring-open analogues 994
Synthesis and biological evaluation of some differently substituted 9,10-anthracenediones 968
Derivatives of BM 212: synthesis and biological evaluation of new derivatives with improved antimycobacterial activity. 960
In vitro antiviral activity of liposomal Artemisia arborescens essential oil 950
null 935
L’OLIO ESSENZIALE DI ARTEMISIA ARBORESCENS INATTIVA HSV1 E HSV2 E INIBISCE LA DIFFUSIONE LATERALE DI CELLULE VERO 927
New pyrrole derivatives of BM 212: lead compound optimization strategy, Tuberculosis drug development. Targets, technologies and trials. 926
Synthesis and antimicrobial activity of novel arylideneisothiosemicarbazones 873
null 826
PHISICAL STABILITY OF ARTEMISIA ARBORESCENS L. ESSENTIAL OIL LOADED SLN AND IN VITRO ANTIVIRAL ACTIVITY 825
null 818
Attività di un derivato isotiosemicarbazonico ciclico nei confronti di biofilm di Candida albicans FLC-S e FLC-R in combinazione con AMB 815
Influenza dell'inclusione liposomiale sull'attività in vitro di miconazolo e ketoconazolo 778
null 764
Aumento della sensibilità all’AmB di biofilm di Candida albicans fluconazolo-resistente nell’impiego combinato con derivati ciclici isotiosemicarbazonici 753
null 736
Effetti dei liposomi sull'attività in vitro di alcuni antifungini 718
L’olio essenziale di Artemisia arborescens inattiva HSV-1 e HSV-2 e inibisce la diffusione laterale in cellule Vero 715
Studio dell’attività di analoghi ciclici isotiosemicarbazonici nei confronti di isolati clinici di Aspergillus spp 672
Strategie alternative per la profilassi delle infezioni sostenute da Candida albicans contratte in ambiente ospedaliero mediante isotiosemicarbazoni ciclici 624
In vitro antimycobacterial activity of newly synthesised S-alkylisothiosemicarbazone derivatives and synergistic interactions in combination with rifamycins against Mycobacterium avium 616
Isothiosemicarbazones as alternative approach to the therapy of infections sustained by Candida albicans 612
null 605
Liposomes as carrier for Artemisia arborescens essential oil: preparation, characterisation and antiviral activity 586
Studio della attività di una nuova classe di isotiosemicarbazoni nei confronti di Aspergillus spp. di isolamento clinico. 585
Degradazione biologica degli aghi di pino (Pinus Silvester) 564
Attività intramacrofagica di nuovi agenti antitubercolari per il trattamento delle infezioni sostenute da ceppi MDR mediante inibizione selettiva della RNA polimerasi. 551
 and  opiate receptors mediate specific behavioral syndromes from the Substantia Nigra. 549
PHYSICAL STABILITY OF ARTEMISIA ARBORESCENS ESSENTIAL OIL LOADED SLN AND IN VITRO ANTIVIRAL ACTIVITY 526
Aspetti microbiologici della produzione farmaceutica 490
null 489
Stafilococchi 483
Validità ai fini diagnostici e terapeutici del test di Meares modificato 482
Aspetti Microbiologici della Produzione Farmaceutica 472
Totale 145.061
Salva come PNG Salva come JPEG
Categoria #
all - tutte 210.315
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 210.315
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022.124 0 0 0 0 8.741 5.735 3.259 747 655 825 743 1.419
2020/202139.024 1.470 1.278 1.827 9.021 7.697 5.002 4.000 2.524 1.105 2.050 1.688 1.362
2021/20228.886 1.427 908 478 567 715 541 389 529 756 769 902 905
2022/202312.524 1.314 1.647 1.447 886 818 1.183 645 1.462 742 620 954 806
2023/202416.879 940 523 1.037 1.211 1.661 3.247 2.625 943 684 1.201 1.491 1.316
2024/202528.064 7.713 11.595 4.674 2.829 1.253 0 0 0 0 0 0 0
Totale 172.344